BRITISH JOURNAL OF HAEMATOLOGY

Abbr. BRIT J HAEMATOL ·ENGLAND ·Frequency Semimonthly ·Avg. articles/yr 319 articles

3.8

Latest IF

7.00%

Self-citation

较易

Submission difficulty

平均1月

Review cycle

About Journal

BRITISH JOURNAL OF HAEMATOLOGY是一本专注于血液学领域的国际学术期刊，ISSN号为0007-1048，由Wiley-Blackwell出版，出版地为英国，出版周期为月刊。该期刊的影响因子较高，属于SCI收录期刊，并且在中科院分区中通常位于医学领域的较高分区。它不是完全开放获取（OA）期刊，但提供部分开放获取选项。该杂志的发文特点涵盖血液学的广泛研究领域，包括血液疾病的基础与临床研究、血液肿瘤、止血与血栓、输血医学等，尤其注重高质量原创研究和综述。杂志的质量较高，审稿严格，学术声誉良好，但投稿竞争激烈，拒稿率较高，可能存在发表周期较长的风险。总体而言，该期刊是血液学领域的重要学术平台，适合从事相关研究的学者投稿和阅读。

IF Trend

Recent Articles

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 <scp>ALLG MM23</scp> ( <scp>SeaLAND</scp> ) trial 2026-09-22

Carrying a crisis: The risk of a painful sickle cell crisis during pregnancy 2026-09-22

From infusion to pills in acute myeloid leukaemia: Reorganizing care beyond the infusion unit 2026-09-20

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia—Final analysis of the international phase <scp>III CLL6 RESIDUUM</scp> study of the <scp>ALLG</scp> and <scp>FILO</scp> groups 2026-09-20

Temporal trends and demographic patterns in depression prevalence among adults with sickle cell disease 2026-09-21

Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification—Insights from chromosome count and cytogenetic abnormalities 2026-09-19

Maternal iron status in pregnancy: The liver as an understudied confounder 2026-09-18

Outcomes for post‐transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre <scp>UK</scp> study 2026-09-18

A phase <scp>IIa</scp> study of the anti‐ <scp>PD</scp> ‐ <scp>L1</scp> antibody avelumab in relapsed/refractory <scp>PTCL</scp> : The <scp>AVAIL</scp> ‐T trial 2026-09-19

Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel‐like factor 1 (KLF‐1)‐E325K‐associated congenital dyserythropoietic anaemia (CDA‐IV) 2026-09-17